Interestingly, the injection of CHOP-competent cancer cells into systemic Chop-deficient mice or Chop-null bone marrow chimeras resulted in a significant anti-tumor effect mediated by CD8+ T cells, suggesting the importance of hematopoietic-intrinsic CHOP in tumor growth and tumor-induced tolerance [77]. Here, DDIT3 is linked to neoplasm.